Skip to main content

Closed

APGE: Apogee Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-24.2%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio32.59×

Apogee Therapeutics, Inc.

APGENASDAQ Global Market·USD·Closed

Apogee Therapeutics, Inc.

APGENASDAQ·USD·Closed

$134.09

−0.16%

$134.09

−$0.21 (0.16%)

52W Range

100thpctl

Volume

0.66×avg

Mkt Cap

8.30BUSD

P/E

-31.0TTM

Div Yield

–ann

52W Range

100thpctl

Volume

0.66×avg

Market Cap

8.30BUSD

P/E Ratio

-31.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings